Literature DB >> 3480422

Human and rat liver phenol sulfotransferase: structure-activity relationships for phenolic substrates.

N R Campbell1, J A Van Loon, R S Sundaram, M M Ames, C Hansch, R Weinshilboum.   

Abstract

Phenol sulfotransferase (PST) catalyzes the sulfate conjugation of many phenolic drugs. Human liver contains thermostable (TS) and thermolabile forms of PST. Ion exchange chromatography shows that two isozymes of TS PST (peaks I and II) are present in human liver preparations. Rat liver contains four forms of PST that can be separated by ion exchange chromatography. Quantitative structure-activity relationship (QSAR) analysis was used to study phenolic substrates for both human and rat liver PST. Thirty-six substituted phenols were tested as substrates for partially purified human liver TS PST peak I. QSAR analysis resulted in derivation of the following equation: log 1/Km = 0.92 (+/- 0.18)log P - 1.48 (+/- 0.38)MR'4 - 0.64 (+/- 0.41)MR3 + 1.04 (+/- 0.63)MR2 + 0.67(+/- 0.44) sigma- + 4.03 (+/- 0.42). In this equation Km is the Michaelis constant, P is the octanol-water partition coefficient, MR is the molar refractivity of substituents at the 2-, 3-, and 4-positions, and sigma- is the Hammett constant. Values of log 1/Km calculated with this equation were highly correlated with log 1/Km values (r = 0.950) that were observed experimentally. Nine phenols were also tested as substrates for partially purified human liver TS PST peak II. Log 1/Km values for these compounds were significantly correlated for the two isozymes of TS PST (r = 0.992, p less than 0.001). QSAR analysis was also used to derive equations that described the behavior of phenolic substrates for rat liver PST forms I and II. These equations differed substantially from the equation derived for compounds tested with human liver TS PST peak I. Therefore, the characteristics of the active sites of human liver TS PST peak I and rat liver PST forms I and II appear to differ. Application of these equations may make it possible to predict Km values of phenolic substrates for human liver TS PST and for rat liver PST forms I and II.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3480422

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  Stereoselective sulphate conjugation of racemic terbutaline by human liver cytosol.

Authors:  T Walle; U K Walle
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

2.  Characterization of bovine tracheobronchial phenol sulphotransferase cDNA and detection of mRNA regulation by cortisol.

Authors:  S J Schauss; T Henry; R Palmatier; L Halvorson; R Dannenbring; J D Beckmann
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

3.  Secretory expression of the rat aryl sulfotransferases IV with improved catalytic efficiency by molecular engineering.

Authors:  Zhengxiong Zhou; Qing Li; Ruirui Xu; Bingbing Wang; Guocheng Du; Zhen Kang
Journal:  3 Biotech       Date:  2019-06-03       Impact factor: 2.406

4.  Substrate specificity of phenol sulfotransferase from primary cultures of bovine brain microvessel endothelium.

Authors:  A Baranczyk-Kuzma; K L Audus; R T Borchardt
Journal:  Neurochem Res       Date:  1989-07       Impact factor: 3.996

5.  Pentachlorophenol and other chlorinated phenols are substrates for human hydroxysteroid sulfotransferase hSULT2A1.

Authors:  Hayrettin Ozan Gulcan; Yungang Liu; Michael W Duffel
Journal:  Chem Res Toxicol       Date:  2008-07-26       Impact factor: 3.739

6.  (+) and (-) terbutaline are sulphated at a higher rate in human intestine than in liver.

Authors:  G M Pacifici; M Eligi; L Giuliani
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 7.  Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A.

Authors:  J G Hengstler; H Foth; T Gebel; P-J Kramer; W Lilienblum; H Schweinfurth; W Völkel; K-M Wollin; U Gundert-Remy
Journal:  Crit Rev Toxicol       Date:  2011-04       Impact factor: 5.635

8.  Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery.

Authors:  Sean Ekins; Jair Lage de Siqueira-Neto; Laura-Isobel McCall; Malabika Sarker; Maneesh Yadav; Elizabeth L Ponder; E Adam Kallel; Danielle Kellar; Steven Chen; Michelle Arkin; Barry A Bunin; James H McKerrow; Carolyn Talcott
Journal:  PLoS Negl Trop Dis       Date:  2015-06-26

Review 9.  High Throughput and Computational Repurposing for Neglected Diseases.

Authors:  Helen W Hernandez; Melinda Soeung; Kimberley M Zorn; Norah Ashoura; Melina Mottin; Carolina Horta Andrade; Conor R Caffrey; Jair Lage de Siqueira-Neto; Sean Ekins
Journal:  Pharm Res       Date:  2018-12-17       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.